EU Explains Plans To Speed Up Variant Vaccine Approvals

New EMA Expert Group Will Probe AZ Vaccine Blood Clot Issue

The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.

Mutating virus concept and new coronavirus variant outbreak or covid-19 viral cell mutation and influenza background as dangerous flu strain medical health risk with disease cells as a 3D render.
Variants of the coronavirus are causing a surge in infections in Europe • Source: Shutterstock

The European Commission has issued draft legislation to speed up the approval of COVID-19 vaccines that have been modified to tackling emerging variants of the SARS-CoV-2 virus.

The “delegated regulation” – published on 24 March – will “allow companies to focus on gathering the necessary evidence in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography